المؤلفون: van Berge Henegouwen, J. M., van der Wijngaart, H., Zeverijn, L. J., Hoes, L. R., Meertens, M., Huitema, A. D. R.^{Aff4, Aff5, Aff6}, Devriese, L. A., Labots, M., Verheul, H. M. W., Voest, E. E., Gelderblom, H.^{Aff1, IDs0028002204437z_cor11}

المصدر: Cancer Chemotherapy and Pharmacology. 90(1):97-104

المؤلفون: van der Velden, D. L.^{Aff1, Aff2}, Hoes, L. R.^{Aff1, Aff2, Aff3}, van der Wijngaart, H.^{Aff2, Aff3, Aff4}, van Berge Henegouwen, J. M.^{Aff2, Aff3, Aff5}, van Werkhoven, E., Roepman, P., Schilsky, R. L., de Leng, W. W. J., Huitema, A. D. R.^{Aff10, Aff11}, Nuijen, B., Nederlof, P. M., van Herpen, C. M. L., de Groot, D. J. A., Devriese, L. A., Hoeben, A., de Jonge, M. J. A., Chalabi, M.^{Aff1, Aff18}, Smit, E. F.^{Aff2, Aff19}, de Langen, A. J., Mehra, N., Labots, M., Kapiteijn, E., Sleijfer, S.^{Aff2, Aff17}, Cuppen, E.^{Aff3, Aff7, Aff20}, Verheul, H. M. W.^{Aff4, Aff13}, Gelderblom, H., Voest, E. E.^{Aff1, Aff2, Aff3, IDs415860191600x_cor27}

المصدر: Nature: International weekly journal of science. 574(7776):127-131

المؤلفون: van Berge Henegouwen JM; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands; Oncode Institute, the Netherlands., Jebbink M; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoes LR; Oncode Institute, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Wijngaart H; Oncode Institute, the Netherlands; Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Zeverijn LJ; Oncode Institute, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Velden DL; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands., Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., van Werkhoven E; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Voest EE; Oncode Institute, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Smit EF; Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: a.j.gelderblom@lumc.nl.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Aug; Vol. 171, pp. 114-123. Date of Electronic Publication: 2022 Jun 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Exons ; Female ; Humans ; Receptor, ErbB-2/metabolism ; Trastuzumab/therapeutic use

المؤلفون: van Waalwijk van Doorn-Khosrovani SB; CZ Health Insurance, Tilburg., Pisters-van Roy A; CZ Health Insurance, Tilburg., van Saase L; National Health Care Institute (Zorginstituut Nederland), Diemen., van der Graaff M; National Health Care Institute (Zorginstituut Nederland), Diemen., Gijzen J; CZ Health Insurance, Tilburg., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam; Center for Personalised Cancer Treatment (CPCT)., Hoes LR; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam., van Berge Henegouwen JM; Division of Medical Oncology, Leiden University Medical Center, Leiden., van der Wijngaart H; Division of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam., van der Velden DL; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam., van Werkhoven E; Department of Biometrics, Netherlands Cancer Institute, Amsterdam., Retel VP; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam; Department of Health Technology and Services Research, University of Twente, Enschede., van Harten WH; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam; Department of Health Technology and Services Research, University of Twente, Enschede; Rijnstate Hospital, Arnhem., Huitema ADR; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Timmers L; National Health Care Institute (Zorginstituut Nederland), Diemen., Gelderblom H; Division of Medical Oncology, Leiden University Medical Center, Leiden., Verheul HMW; Division of Medical Oncology, Leiden University Medical Center, Leiden., Voest EE; Center for Personalised Cancer Treatment (CPCT); Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam. Electronic address: e.voest@nki.nl.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 May 01; Vol. 30 (5), pp. 663-665.

نوع المنشور: Editorial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*genetics , Neoplasms/*drug therapy , Neoplasms/*economics , Precision Medicine/*economics , Reimbursement Mechanisms/*economics, Biomarkers, Tumor/metabolism ; Cost-Benefit Analysis ; Health Services Accessibility/economics ; Humans ; Molecular Diagnostic Techniques/economics ; Molecular Targeted Therapy/economics ; Neoplasms/classification ; Neoplasms/genetics ; Netherlands ; Survival Rate

المؤلفون: Van Berge Henegouwen JM; Department of Infectious Diseases and Internal Medicine, Leiden University Medical Centre, Leiden, the Netherlands., Groeneveld GH, de Boer MGJ, Visser LG

المصدر: The Netherlands journal of medicine [Neth J Med] 2017 Dec; Vol. 75 (10), pp. 462-463.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Van Zuiden Communications Country of Publication: Netherlands NLM ID: 0356133 Publication Model: Print Cited Medium: Internet ISSN: 1872-9061 (Electronic) Linking ISSN: 03002977 NLM ISO Abbreviation: Neth J Med Subsets: PubMed not MEDLINE